AVERSA, Franco
 Distribuzione geografica
Continente #
NA - Nord America 2.396
EU - Europa 1.787
AS - Asia 1.450
SA - Sud America 218
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.872
Nazione #
US - Stati Uniti d'America 2.343
SG - Singapore 645
IE - Irlanda 347
UA - Ucraina 309
SE - Svezia 252
CN - Cina 245
IT - Italia 224
HK - Hong Kong 209
BR - Brasile 189
RU - Federazione Russa 167
FI - Finlandia 143
VN - Vietnam 142
DE - Germania 127
KR - Corea 92
GB - Regno Unito 71
CA - Canada 33
FR - Francia 31
IN - India 26
TR - Turchia 25
PL - Polonia 18
NL - Olanda 16
AR - Argentina 15
BE - Belgio 15
AT - Austria 14
CZ - Repubblica Ceca 14
JP - Giappone 14
BD - Bangladesh 11
CH - Svizzera 11
MX - Messico 11
ZA - Sudafrica 11
UZ - Uzbekistan 9
IQ - Iraq 7
GR - Grecia 6
RO - Romania 5
EC - Ecuador 4
ES - Italia 4
LB - Libano 4
KE - Kenya 3
PK - Pakistan 3
PY - Paraguay 3
BG - Bulgaria 2
BO - Bolivia 2
CO - Colombia 2
CR - Costa Rica 2
HN - Honduras 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
LT - Lituania 2
LV - Lettonia 2
NP - Nepal 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BB - Barbados 1
BY - Bielorussia 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
ID - Indonesia 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
NR - Nauru 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
TW - Taiwan 1
YT - Mayotte 1
Totale 5.872
Città #
Singapore 430
Chandler 393
Dublin 345
Hong Kong 209
San Mateo 200
Jacksonville 169
Boardman 136
Ashburn 125
Santa Clara 96
Seoul 86
Perugia 80
Dong Ket 77
Medford 69
Beijing 68
Princeton 68
Ann Arbor 58
Moscow 57
Andover 55
Munich 51
Altamura 50
New York 47
Helsinki 46
Wilmington 44
Lawrence 42
Los Angeles 37
Piscataway 36
Turku 32
Ho Chi Minh City 24
Houston 22
São Paulo 22
Des Moines 21
Saint Petersburg 21
Brooklyn 17
Hanoi 17
Woodbridge 17
Norwalk 16
Montreal 14
Shanghai 14
Tokyo 14
Brussels 13
Izmir 13
San Francisco 13
Auburn Hills 11
Johannesburg 11
San Paolo di Civitate 11
Stockholm 11
Dallas 10
The Dalles 10
Vienna 10
Warsaw 10
Amsterdam 9
Brno 9
Orem 9
Phoenix 9
Seattle 9
Atlanta 8
Chicago 8
London 8
Nuremberg 8
Chennai 7
Dearborn 7
Espoo 7
Rio de Janeiro 7
Tashkent 7
Bologna 6
Denver 6
Falls Church 6
Ottawa 6
Renton 6
Toronto 6
Boston 5
Columbus 5
Frankfurt am Main 5
Guangzhou 5
Manchester 5
Poplar 5
Rome 5
Tianjin 5
Brasília 4
Council Bluffs 4
Falkenstein 4
Hanover 4
Hefei 4
New Delhi 4
Olomouc 4
Osasco 4
Redmond 4
Redwood City 4
Salerno 4
San Diego 4
Secaucus 4
Wroclaw 4
Ankara 3
Aurora 3
Changsha 3
Charlotte 3
Curitiba 3
Den Haag 3
Foligno 3
Groningen 3
Totale 3.716
Nome #
Advances in full-haplotype mismatched transplants in acute leukemia 162
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 131
Acute lymphoblastic leukaemia in Noonan syndrome 120
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. 116
Graft engineering for allogeneic haploidentical stem cell transplantation 115
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 110
Fourth international workshop on haploidentical transplants, Naples, Italy 109
A multidrug-resistant Pseudomonas aeruginosa isolate from a lethal case of sepsis induces necrosis of human neutrophils 109
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 105
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 103
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 103
"Designed" grafts for HLA-haploidentical stem cell transplantation. 101
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 101
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 100
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 100
Toxoplasma gondii infection in bone marrow transplant recipients: the polymerase chain reaction-blood sample combination in diagnosis and early detection. 96
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 92
Competing risks analysis using R: an easy guide for clinicians 91
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 90
Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia. 90
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 90
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 90
Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite 90
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants 90
Haploidentical stem cell transplantation for acute leukemia 89
Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation. 88
Genetic polymorphisms affecting IDO1 or IDO2 activity differently associate with aspergillosis in humans 87
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 85
Mismatched hematopoietic stem cell transplantation in secondary leukemia 83
Totipotent stem cells bearing del(20q) maintain multipotential differentiation in Shwachman Diamond syndrome 83
Hematopoietic stem cell transplantation (HSCT) from alternative donors for acute leukemia at high-risk of relapse. the haploidentical option. 82
Pharyngeal microbial signatures are predictive of the risk of fungal pneumonia in hematologic patients 82
PML is required for telomere stability in non-neoplastic human cells 81
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 81
Stem cell mobilization in normal donors. 80
Full-haplotype mismatched HSCT for high risk acute myeloid leukemia (AML). 80
Haploidentical transplantation and natural killer cell recognition of missing self. 79
Cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation 77
Deploying natural killer cell allotherapy in the setting of HLA-haplotype-mismatched hematopoietic stem cell transplantation 77
New mechanism of lymphoma-induced bone marrow aplasia 75
Infezioni da Cytomegalovirus nel paziente immunodepresso. 74
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. 70
Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation. 70
Prospects for dendritic cell vaccination against fungal infections in hematopoietic transplantation 69
Improved Outcome With T-Cell–Depleted Bone Marrow Transplantation for Acute Leukemia 69
Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL) 68
Outcomes of unrelated cord blood and haploidentical stem cell transplantation in adults with acute leukaemia. 68
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 66
Natural killer cell allorecognition of missing self in allogenic hematopoietic transplantation :a tool for immunotherapy of leukemia. 66
Full-haplotype mismatched HSCT is a valid option for high-risk acute myeloid leukemia (AML) patients. 66
Stem cell transplantation from full-haplotype mismatched donors in leukemia . 64
Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use 64
null 63
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 61
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 61
Outcomes after CD34+ positive immunoselection for haploidentical transplants in high-risk acute leukemia. 60
Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option. 60
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 59
Provision of antifungal immunity and concomitant alloantigen tolerization by conditioned dendritic cells in experimental hematopoietic transplantation. 57
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 56
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 56
The haploidentical option for high-risk haematological malignancies. 56
The Evolution of T Cell Depleted Haploidentical Transplantation 56
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 54
Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases 54
Regression Modeling of Competing Risk Using R: An In Depth Guide for Clinicians 53
Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia. 53
The role of bronchoalveolar lavage (BAL) in immunocompromised haematological patients. 51
Natural killer cells as a therapeutic tool in mismatched transplantation 51
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 50
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 48
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 48
null 46
Haploidentical stem cell transplantation in leukemia 44
Hairy cell leukaemia mimicking multiple myeloma 44
T-cell–depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT) 40
Hematopoietic Cell Transplantation from Human Leukocyte Antigen Partially Matched Related Donors 37
null 36
Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: harnessing natural and adaptive immunity. 36
null 11
Totale 6.028
Categoria #
all - tutte 28.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.122


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021353 0 0 0 0 0 44 50 5 75 31 58 90
2021/2022650 13 165 25 47 19 4 9 190 6 13 73 86
2022/20231.202 81 197 9 102 129 118 2 66 443 11 34 10
2023/2024491 26 60 25 8 8 6 108 12 61 18 73 86
2024/20251.108 26 119 67 59 123 44 69 60 192 58 193 98
2025/20261.291 164 151 101 320 380 175 0 0 0 0 0 0
Totale 6.028